A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
Hongxiang Wei,1,* Jinyuan Chen,2,* Shenglin Wang,1,* Feihuan Fu,3 Xia Zhu,1 Chaoyang Wu,1 Zhoujie Liu,4 Guangxian Zhong,1 Jianhua Lin1 1Department of Orthopaedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China; 2Department of Centrala...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-11-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-nanodrug-consisting-of-doxorubicin-and-exosome-derived-from-mesenchy-peer-reviewed-article-IJN |
| _version_ | 1831833874527682560 |
|---|---|
| author | Wei H Chen J Wang S Fu F Zhu X Wu C Liu Z Zhong G Lin J |
| author_facet | Wei H Chen J Wang S Fu F Zhu X Wu C Liu Z Zhong G Lin J |
| author_sort | Wei H |
| collection | DOAJ |
| description | Hongxiang Wei,1,* Jinyuan Chen,2,* Shenglin Wang,1,* Feihuan Fu,3 Xia Zhu,1 Chaoyang Wu,1 Zhoujie Liu,4 Guangxian Zhong,1 Jianhua Lin1 1Department of Orthopaedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China; 2Department of Centralab, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China; 3Department of Endocrinology, The County Hospital of Anxi, Anxi 362400, People’s Republic of China; 4Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guangxian Zhong; Jianhua LinDepartment of Orthopaedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of ChinaTel/fax +86 591 87981029Email zhongguangxian@163.com; jianhual@126.comPurpose: The primary goal of the present study was to develop the nano-drug consisting of doxorubicin and exosome derived from mesenchymal stem cells, and to explore its effect on osteosarcoma in vitro.Methods: The exosomes were isolated from bone marrow MSCs (BM-MSCs) by an Exosome Isolation Kit. The exosome-loaded doxorubicin (Exo-Dox) was prepared by mixing exosome with Dox-HCl, desalinizing with triethylamine and then dialyzing against PBS overnight. The nanoparticle tracking analysis (NTA) and transmission electron microscope (TEM) were used to characterize of the exosome and Exo-Dox. The cytotoxicity of Exo-Dox was determined by CCK-8 assay. Further, the cellular uptake of different drugs was analyzed using inverted fluorescence microscope and flow cytometry.Results: The typical exosome structures can be observed by TEM. After loading with doxorubicin, its size is larger than free exosome. Compared with the free Dox, the prepared Exo-Dox showed enhanced cellular uptake efficiency and anti-tumor effect in osteosarcoma MG63 cell line but low cytotoxicity in myocardial H9C2 cell line.Conclusion: The prepared Exo-Dox could be used as an excellent chemotherapeutic drug for treatment of osteosarcoma in vitro. Considering the tumor-homing feature of BM-MSCs, the Exo-Dox may be a good candidate for targeted osteosarcoma treatment in future study.Keywords: exosome, mesenchymal stem cells, doxorubicin, osteosarcoma
|
| first_indexed | 2024-12-23T04:01:48Z |
| format | Article |
| id | doaj.art-ffaea1b0c4c44b5a96d9c0d9f44eb129 |
| institution | Directory Open Access Journal |
| issn | 1178-2013 |
| language | English |
| last_indexed | 2024-12-23T04:01:48Z |
| publishDate | 2019-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj.art-ffaea1b0c4c44b5a96d9c0d9f44eb1292022-12-21T18:00:43ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-11-01Volume 148603861049466A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In VitroWei HChen JWang SFu FZhu XWu CLiu ZZhong GLin JHongxiang Wei,1,* Jinyuan Chen,2,* Shenglin Wang,1,* Feihuan Fu,3 Xia Zhu,1 Chaoyang Wu,1 Zhoujie Liu,4 Guangxian Zhong,1 Jianhua Lin1 1Department of Orthopaedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China; 2Department of Centralab, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China; 3Department of Endocrinology, The County Hospital of Anxi, Anxi 362400, People’s Republic of China; 4Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guangxian Zhong; Jianhua LinDepartment of Orthopaedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of ChinaTel/fax +86 591 87981029Email zhongguangxian@163.com; jianhual@126.comPurpose: The primary goal of the present study was to develop the nano-drug consisting of doxorubicin and exosome derived from mesenchymal stem cells, and to explore its effect on osteosarcoma in vitro.Methods: The exosomes were isolated from bone marrow MSCs (BM-MSCs) by an Exosome Isolation Kit. The exosome-loaded doxorubicin (Exo-Dox) was prepared by mixing exosome with Dox-HCl, desalinizing with triethylamine and then dialyzing against PBS overnight. The nanoparticle tracking analysis (NTA) and transmission electron microscope (TEM) were used to characterize of the exosome and Exo-Dox. The cytotoxicity of Exo-Dox was determined by CCK-8 assay. Further, the cellular uptake of different drugs was analyzed using inverted fluorescence microscope and flow cytometry.Results: The typical exosome structures can be observed by TEM. After loading with doxorubicin, its size is larger than free exosome. Compared with the free Dox, the prepared Exo-Dox showed enhanced cellular uptake efficiency and anti-tumor effect in osteosarcoma MG63 cell line but low cytotoxicity in myocardial H9C2 cell line.Conclusion: The prepared Exo-Dox could be used as an excellent chemotherapeutic drug for treatment of osteosarcoma in vitro. Considering the tumor-homing feature of BM-MSCs, the Exo-Dox may be a good candidate for targeted osteosarcoma treatment in future study.Keywords: exosome, mesenchymal stem cells, doxorubicin, osteosarcoma https://www.dovepress.com/a-nanodrug-consisting-of-doxorubicin-and-exosome-derived-from-mesenchy-peer-reviewed-article-IJNexosomemesenchymal stem cellsdoxorubicinosteosarcoma |
| spellingShingle | Wei H Chen J Wang S Fu F Zhu X Wu C Liu Z Zhong G Lin J A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro International Journal of Nanomedicine exosome mesenchymal stem cells doxorubicin osteosarcoma |
| title | A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro |
| title_full | A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro |
| title_fullStr | A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro |
| title_full_unstemmed | A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro |
| title_short | A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro |
| title_sort | nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro |
| topic | exosome mesenchymal stem cells doxorubicin osteosarcoma |
| url | https://www.dovepress.com/a-nanodrug-consisting-of-doxorubicin-and-exosome-derived-from-mesenchy-peer-reviewed-article-IJN |
| work_keys_str_mv | AT weih ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT chenj ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT wangs ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT fuf ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT zhux ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT wuc ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT liuz ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT zhongg ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT linj ananodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT weih nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT chenj nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT wangs nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT fuf nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT zhux nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT wuc nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT liuz nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT zhongg nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro AT linj nanodrugconsistingofdoxorubicinandexosomederivedfrommesenchymalstemcellsforosteosarcomatreatmentinvitro |